Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;71(5):347-350.
doi: 10.5455/medarh.2017.71.347-350.

Blood Count of Eosinophil Polymorphonuclear Leucocytes and Bronchial Hyperreactivity in Chronic Obstructive Pulmonary Disease

Vesna Cukic  1
Affiliations

Blood Count of Eosinophil Polymorphonuclear Leucocytes and Bronchial Hyperreactivity in Chronic Obstructive Pulmonary Disease

Vesna Cukic. Med Arch. 2017 Oct.

Abstract

Introduction: Polymorphonuclear eosinophil leucocytes (eosinophils) are found in increased numbers in the circulation and sputum in asthma patients, usually in relation to the severity of asthma but it is the question whether they have a significant role in the development and level of bronchial hyperreactivity in patients with chronic obstructive pulmonary disease (COPD).

Objective: to show the role of the eosinophils in the development and level of BHR in patients with COPD and so in the severity of illness.

Material and methods: We observed 240 patients with COPD treated in Clinic for Pulmonary Diseases and TB «Podhrastovi» Sarajevo during five years: from 2012 to 2016. They were divided into groups and subgroups according to the first registration of BHR in the course of illness and to the number of exacerbations of the disease in one year. The number of blood eosinophils was measured at the onset of exacerbation of the disease before switching on any therapy, at the beginning and at the end of the research.

Results: we did not find any significant difference in the eosinophil blood count between the COPD patients with and without BHR, nor according to the time of the first registration of BHR in the course of illness nor according to the number of exacerbations of illness per one year. There was not statistically significant difference in eosinophil count (increase-drop) within any of the groups or subgroups, or between the groups and subgroups between the first and last test.

Conclusion: There is not significant correlation between the eosinophil blood count and the level of BHR, number of exacerbations and the severity of COPD.

Keywords: BHR; COPD; polymorphonuclear eosinophil leucocytes.

PubMed Disclaimer

Conflict of interest statement

• Conflict of interest: none declared.

Figures

Figure 1
Figure 1
Number of blood eosinophils in COPD patients according to the time of registration of BHR in the course of disease and to the number of exacerbations per year. Legend: groups (time of registration of BHR): 1. = 0-1 year, 2. = 1- 3 years, 3. = more than 3 years after the diagnosis of COPD; subgroups: a= l or less, b=2-3, c= more than 3 exacerbations per year
Figure 2
Figure 2
Number of blood eosinophils in all COPD patients according to the number of exacerbations per year. Legend: subgroups: a= l or less, b=2-3, c= more than 3 exacerbations per year. Ex=examination, diff. = difference
See this image and copyright information in PMC

References

    1. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709–21. - PubMed
    1. Bahous J, Cartier A. Non Allergic Bronchial Hyperreactivity in COPD. Am Rev Resp Dis. 1989;139:844–8.
    1. Saetta M, Furato G, Maeshelli P, Mopp C, Fabri LM. Cellular and structural bases of COPD. Am J Respir Care Critic Care Med. 2001;163(6):1304–9. - PubMed
    1. Busse WW, Sedgwick JB. Eosinophils in asthma. Ann Allergy. 1992 Mar;68(3):86–90. - PubMed
    1. Denburg JA. Bone marrow in atopy and asthma: haematopoietic mechanisms in allergic inflammation. Immunol Today. 1999;20:111–3. - PubMed

MeSH terms

LinkOut - more resources